CellSeed Inc. (TYO:7776)
Japan · Delayed Price · Currency is JPY 349.00
-5.00 (-1.41%)
At close: Mar 6, 2026
CellSeed Revenue
In the year 2021, CellSeed had annual revenue of 161.00M JPY, down -19.10%. CellSeed had revenue of 33.00M in the quarter ending December 31, 2021, a decrease of -71.55%.
Revenue
161.00M
Revenue Growth
-19.10%
P/S Ratio
80.13
Revenue / Employee
3.66M
Employees
44
Market Cap
12.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 161.00M | -38.00M | -19.10% |
| Dec 31, 2020 | 199.00M | -76.00M | -27.64% |
| Dec 31, 2019 | 275.00M | -751.00M | -73.20% |
| Dec 31, 2018 | 1.03B | 941.00M | 1,107.06% |
| Dec 31, 2017 | 85.00M | -15.00M | -15.00% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 7.06B |
| StemCell Institute | 2.78B |
| ReproCELL | 2.52B |
| Immuno-Biological Laboratories | 1.03B |
| Stella Pharma | 968.00M |
| Nano Holdings | 155.00M |
| Kubota Pharmaceutical Holdings | 21.34M |
| BrightPath Biotherapeutics | 1.11M |